Introduction {#Sec1}
============

Sphingolipids are an important lipid class that is present in all higher organisms. Ceramide (Cer) is the key compound on the crossroads of sphingolipid metabolism. Ceramide mediates a number of biological processes, including apoptosis, proliferation, differentiation, growth arrest, inflammation and heat stress response \[[@CR1]--[@CR4]\]. The variety of cellular effects of ceramide can be attributed to its ability to alter the activity of kinases, phosphatases and transcription factors \[[@CR5]--[@CR7]\]. Other sphingolipid intermediates, such as sphingosine (Sph), sphingosine-1-phosphate (S1P), ceramide-1-phosphate are also important second messengers \[[@CR8]--[@CR12]\]. The cellular content of ceramide is determined by a balance between the rate of its formation and degradation. There are two major types of ceramides production. One of them is hydrolysis of sphingomyelin and the other one is de novo biosynthesis. Sphingomyelin is located in the plasma membrane, in lysosomes, and in endosomes. Its hydrolysis is catalyzed by the neutral and acid sphingomyelinase (n- and aSMase). De novo synthesis is initiated by condensation of serine with palmitoyl-CoA to generate 3-ketosphinganine \[[@CR13]\]. This, the rate-limiting step in de novo sphingolipid biosynthesis is catalyzed by the enzyme serine-palmitoyltransferase (SPT). 3-Ketosphingosine is rapidly reduced to sphinganine (SPA) by the action of the enzyme 3-ketosphinganine reductase. Next, SPA is acylated to form dihydroceramide by the action of dihydroceramide synthase. The last step of ceramide synthesis is conversion of dihydroceramide to ceramide by insertion of a 4,5-*trans*-double bond into dihydroceramide. This reaction is catalyzed by the enzyme dihydroceramide desaturase \[[@CR13]\]. Ceramide is hydrolyzed by the enzyme ceramidase (CDase) to yield a free fatty acid and sphingosine. There are three isoforms of ceramidase: acid (aCDase), neutral (nCDase) and alkaline (alCDase). By the use of enzymatic assay and Northern blot analysis almost no activity or mRNA of aCDase was found in skeletal muscle \[[@CR14]\].

Ceramide has been shown to be present in skeletal muscle \[[@CR15]--[@CR17]\]. Its content in the muscles depends on the muscle type. The higher content of ceramide was observed in muscle composed mostly of oxidative fibers than in muscle composed mostly of glycolytic fibers \[[@CR16]\]. Skeletal muscles are responsible for 70--80% of whole body insulin-stimulated glucose uptake \[[@CR18], [@CR19]\]. Recent evidence suggests that the accumulation of intramuscular lipids is involved in the induction of insulin-resistance \[[@CR20], [@CR21]\]. One candidate for this action is ceramide \[[@CR17]\]. The intracellular level of ceramide is increased in the muscles of obese, insulin-resistant Zucker rats \[[@CR22]\] and obese insulin-resistant humans \[[@CR17]\]. Adams et al. reported that ceramide content increased nearly twofold in skeletal muscles of obese humans. It is also well known that trained subjects are more insulin sensitive than sedentary subjects \[[@CR23], [@CR24]\].

A previous study showed that endurance training decreases the total content of sphingomyelin and ceramides, increases the content of sphinganine, does not affect the sphingosine content, and increases nSMase activity \[[@CR25]\]. Moreover, sphingolipid content and the activity of enzymes of ceramide metabolism both depend on the duration of exercise and muscle type \[[@CR26]\]. In the mentioned study, the ceramide level decreased after 30 min of running but increased after exhaustive exercise \[[@CR26]\]. Data obtained from human skeletal muscle showed that training did not change either ceramide content or nSMase activity \[[@CR27]\]. There was no data on the effect of training on the activity of SPT, acid sphingomyelinase and ceramidases in rat skeletal muscles. Therefore the aim of the present study was to examine the effect of training on the activity of key enzymes of ceramide metabolism and selected sphingolipid intermediates in skeletal muscle.

Materials and Methods {#Sec2}
=====================

Animals and Study Design {#Sec3}
------------------------

The investigation was approved by the Ethical Committee for Animal Experiments at the Medical University of Bialystok. The experiments were carried out on male Wistar rats (200--250 g) fed ad libitum on commercial food pellets for rodents. Animals were housed in standard conditions (21 ± 2 °C, 12 h light/12 h dark cycle) with free access to tap water and food pellets. The animals were randomly divided into two groups (*N* = 8 in each group): (1) sedentary (control) (2) trained for 5 weeks on an electrically driven treadmill according to the following protocol \[[@CR28]\]: 1st week 1 h daily at a speed of 960 m/h. The same running time was applied during successive weeks but the running speed was increased as follows: 2nd week 1,200 m/h, 3rd week 1,440 m/h, 4th--6th week 1,680 m/h. This type of training was previously found to affect ceramide metabolism in both cardiac and skeletal muscle of the rat \[[@CR25], [@CR29]\]. Twenty four hours after the last exercise bout in the training program, the rats were anaesthetized along with the controls with pentobarbital sodium administered intraperitoneally at a dose of 80 mg/kg. The soleus and the red and white sections of the gastrocnemius were excised, cleaned of any visible adipose tissue, nerves, and fascias and frozen in liquid nitrogen. These muscles are composed predominantly of slow-twitch oxidative, fast-twitch oxidative-glycolytic, and fast-twitch glycolytic fibers, respectively \[[@CR30], [@CR31]\]. We used a homeostasis model assessment for calculating insulin resistance (HOMA-IR) in both groups.

The Content of Sphingosine, Sphinganine and Sphingosine-1-phosphate {#Sec4}
-------------------------------------------------------------------

The content of Sph, SPA and S1P was measured using the method previously described by Min et al. \[[@CR32]\]. Internal standards (C17-sphingosine and C17-S1P, Avanti Polar Lipids) were added to the samples before homogenization and ultrasonication. The dried lipid residues were redissolved in ethanol and sphingoid bases were converted to their *o*-phthalaldehyde derivatives and analyzed on an HPLC system (ProStar, Varian Inc.) equipped with a fluorescence detector and C18 reversed-phase column (Varian Inc. OmniSpher 5, 4.6 × 150 mm). The isocratic eluent composition of acetonitrile (Merck): water (9:1 v/v) and a flow rate of 1 ml/min were used. The column temperature was maintained at 33 °C. Figure [1](#Fig1){ref-type="fig"} presents a chromatogram showing the separation of sphingolipids. Figure [2](#Fig2){ref-type="fig"} shows the standard curve of SPA, Cer, Sph and S1P.Fig. 1HPLC chromatography separation of sphingolipidsFig. 2Standard curve of sphinganine (**a**), ceramides (**b**), sphingosine (**c**), sphingosine-1-phosphate (**d**)

The Content of Ceramide and Dihydroceramide {#Sec5}
-------------------------------------------

A small volume of the chloroform phase containing lipids extracted as described above was transferred to a fresh tube containing 31 pmol of C17-sphingosine as an internal standard. The samples were evaporated under a nitrogen stream, redissolved in 1 M KOH in 90% methanol and heated at 90 °C for 60 min to convert ceramide into sphingosine. This digestion procedure does not convert complex sphingolipids, such as sphingomyelin, galactosylceramide or glucosylceramide, into free sphingoid bases \[[@CR33]\]. Samples were then partitioned by the addition of chloroform and water. The upper phase was discarded and the lower phase was evaporated under nitrogen. The content of free sphingosine liberated from ceramide was then analyzed by means of HPLC as described above. The calibration curves were prepared using *N*-palmitoylsphingosine and *N*-palmitoylsphinganine (Avanti Polar Lipids, Alabaster, AL, USA) as standards. The chloroform extract used for the analysis of Cer and dhCer levels also contains small amounts of free sphingoid bases. Therefore, the content of ceramide and dihydroceramide was corrected for the level of free sphingosine and sphinganine, respectively, as determined in the same sample.

The Activity of Sphingomyelinases {#Sec6}
---------------------------------

The activity of n- and aSMase was determined according to Liu and Hannun \[[@CR34]\]. The activity of both sphingomyelinases was measured with the use of radiolabeled substrate \[*N*-methyl-^14^C\]-sphingomyelin (Perkin-Elmer Life Sciences). The product of reaction---^14^C-choline phosphate---was extracted with CHCl~3~:methanol (2:1, v/v), transferred to scintillation vials and counted using a Packard TRI-CARB 1900 TR scintillation counter.

The Activity of Ceramidases {#Sec7}
---------------------------

The activity of alCDase and nCDase was measured by the method of Nikolova-Karakashian and Merrill \[[@CR35]\]. The activity of the enzymes was determined with the use of radiolabeled \[*N*-palmitoyl-1-^14^C\]-sphingosine (Moravek Biochemicals) as a substrate. Unreacted ceramide and liberated ^14^C-palmitate were separated with basic Dole solution (isopropanol:heptane:1 N NaOH, 40:10:1, v/v/v). Radioactivity of the ^14^C-palmitate was measured by scintillation counting.

The Activity of Serine Palmitoyltransferase {#Sec8}
-------------------------------------------

The activity of SPT was examined as described by Merrill \[[@CR36]\] with the use of a radiolabeled substrate, \[^3^H\]-[l]{.smallcaps}-serine (Moravek Biochemicals). Briefly, rat skeletal muscle microsomal fraction was obtained by ultracentrifugation at 150,000*g* for 40 min. Microsomes were incubated for 10 min at 37 °C in the reaction buffer (100 mM HEPES (pH 8.3), 5 mM DTT (dithiothreitol), 2.5 mM EDTA (pH 7.0), 50 μM pyridoxal phosphate, 200 μM palmitoyl-CoA and 2 mM [l]{.smallcaps}-serine, 44,000 dpm/nmol). The labeled lipid product 3-ketosphinganine was extracted with CHCl~3~:methanol (1:2, v/v) and the radioactivity was measured by scintillation counting.

Plasma Insulin and Glucose Concentration {#Sec9}
----------------------------------------

The plasma insulin concentration was determined using an ELISA kit (Mercodia Insulin ELISA kit). The plasma glucose concentration was measured using the Glucose Ox Liquid Kit (Pointe Scientific).

Plasma Free Fatty Acids (FFA) Concentration {#Sec10}
-------------------------------------------

The FFA concentration was determined using the Wako NEFA C kit (Wako Chemicals).

Statistical Analysis {#Sec11}
--------------------

All data are presented as means ± SD. Data were analyzed by one-way analysis of variance (ANOVA), followed by the Newman--Keuls post hoc test. *p* values \<0.05 were taken to indicate statistical significance.

Results {#Sec12}
=======

Plasma FFA, Glucose and Insulin Concentration and HOMA-IR {#Sec13}
---------------------------------------------------------

The cellular ceramide level depends on the availability of plasma FFA. Circulating FFA must be converted to their active form---fatty acyl coenzyme A---after entering the cell in order to participate in further metabolic processes. Acyl-CoA is used as a substrate in the de novo sphingolipids biosynthesis. In our study the plasma FFA concentration decreased from 260 ± 17 nmol × ml^−1^ (control group) to 111.06 nmol × ml^−1^ (*p* \< 0.01) (training group) (Table [1](#Tab1){ref-type="table"}). To estimate the insulin sensitivity we measured fasting plasma insulin and glucose concentration for HOMA-IR calculation. The equation for calculating HOMA-IR was as follows: HOMA-IR = (fasting plasma glucose × fasting plasma insulin)/2,430, where fasting plasma glucose was in mg/dl and fasting plasma insulin in μU/ml \[[@CR37]\]. Both plasma glucose and insulin concentration were significantly lower in the trained group compared to the sedentary group (Table [1](#Tab1){ref-type="table"}). We found that HOMA-IR values were lower in the trained group (HOMA-IR~trained~ = 0.54) than in the sedentary group (HOMA-IR~sedentary~ = 1.13) which means that exercised animals were more insulin sensitive than sedentary rats.Table 1Effect of training on plasma free fatty acid, glucose and insulin concentrationControlTrainingPlasma FFA concentration (nmol × ml^−1^)260 ± 17111.06 ± 15^b^Plasma glucose concentration (mg/dl)140.76 ± 16.690.18 ± 11.8^a^Plasma insulin concentration (µU/ml)19.6 ± 2.414.6 ± 2.1^a^HOMA-IR1.13 ± 0.100.54 ± 0.04^b^Values are means ± SD (*n* = 8 in each group). The rats were either sedentary (control) or trained on the electrically driven treadmill as described in the methodsHOMA-IR = \[fasting glucose (mg/dl) × fasting insulin (µU/ml)\]/2,430*FFA* free fatty acids^a^*p* \< 0.01, ^b^ *p* \< 0.001 versus the control group

The Content of Skeletal Muscle Sphingolipids (Table [2](#Tab2){ref-type="table"}) {#Sec14}
---------------------------------------------------------------------------------

Sphingolipids, especially ceramides, are very active biologically and mediate a number of biological processes. It seems that ceramides play an important role in the induction of different diseases states such as insulin resistance \[[@CR38], [@CR39]\]. Data from our previous study showed that ceramide metabolism changes with the duration of single-bout exercise \[[@CR26]\]. In the present study we wanted to examine how training affects sphingolipids content and enzymes activities implicated in ceramide metabolism in skeletal muscle. Therefore we measured the content of the following sphingolipids: sphingosine, sphingosine-1-phosphate, sphinganine, sphinganine-1-phosphate (SPA1P), ceramides and dihydroceramide (dhCer). The content of Sph (Fig. [3](#Fig3){ref-type="fig"}a) and S1P (Fig. [3](#Fig3){ref-type="fig"}b) did not change in any studied muscle after endurance training. SPA level increased by 52% (*p* \< 0.01) and 41% (*p* \< 0.01) in the soleus and red section of the gastrocnemius, respectively, compared to the control group. There was no difference in the SPA content in the white section of the gastrocnemius between trained and sedentary groups (Fig. [3](#Fig3){ref-type="fig"}c). The content of sphinganine-1-phosphate increased in both sections of the gastrocnemius in trained animals. In the red section of the gastrocnemius the SPA1P level was 50% (*p* \< 0.01) higher than in the same muscle in the control group. In the white section of the gastrocnemius the SPA1P level was almost four times higher (*p* \< 0.001) then in the same muscle from the sedentary group (Fig. [3](#Fig3){ref-type="fig"}d). The content of ceramide and dhCer did not change in any studied muscle from the trained group (Fig. [3](#Fig3){ref-type="fig"}e, f).Table 2Effect of training on the content of sphingolipids in rat skeletal muscleSphingosineSphinganineS1PCeramideSPA1PdhCerControlTrainingControlTrainingControlTrainingControlTrainingControlTrainingControlTrainingSoleus1.00 ± 0.171.17 ± 0.210.39 ± 0.060.59 ± 0.11^a^0.22 ± 0.040.27 ± 0.0424.57 ± 3.5328.70 ± 3.590.224 ± 0.070.202 ± 0.050.836 ± 0.190.891 ± 0.15RG1.00 ± 0.241.20 ± 0.260.38 ± 0.080.54 ± 0.09^a^0.25 ± 0.060.28 ± 0.0324.57 ± 3.6324.60 ± 3.130.167 ± 0.060.269 ± 0.06^a^0.990 ± 0.281.003 ± 0.24WG0.51 ± 0.080.59 ± 0.060.21 ± 0.020.27 ± 0.050.09 ± 0.010.11 ± 0.0422.05 ± 3.9723.32 ± 3.400.093 ± 0.040.337 ± 0.04^b^1.059 ± 0.330.956 ± 0.26Values are means ± SD (*n* = 8 in each group). The rats were either sedentary (control) or trained on the electrically driven treadmill as described in the methods*RG* red section of the gastrocnemius, *WG* white section of the gastrocnemius, *S1P* sphingosine-1-phosphate, *SPA1P* sphinganine-1-phosphate, *dhCer* dihydroceramide^*a*^*p* \< 0.01, ^b^ *p* \< 0.001 versus the control groupFig. 3Effect of training on the content of sphingosine (**a**), sphingosine-1-phosphate (**b**), sphinganine (**c**), sphinganine-1-phosphate (**d**), ceramide (**e**) and dihydroceramide (**f**) in three types of rat skeletal muscles. Values are means ± SD (*n* = 8 in each group). The rats were either sedentary (control) or trained on an electrically driven treadmill as described in the methods. ^b^*p* \< 0.01, ^c^*p* \< 0.001 versus the control group. RG, *redsection* of the gastrocnemius; WG, *whitesection* of the gastrocnemius

The Enzymes of Ceramide Metabolism (Table [3](#Tab3){ref-type="table"}) {#Sec15}
-----------------------------------------------------------------------

The activities of the key enzymes implicated in ceramides metabolism: SPT, nSMase, aSMase (enzymes responsible for ceramides generation) and nCDase and alCDase (enzymes responsible for ceramides degradation) were measured. There are limited data about the activity of the above-mentioned enzymes in skeletal muscle. The only available data on the activity of all the enzymes in muscle refer to the enzymes' activity at rest, after a single-bout of exercise \[[@CR26]\], from diabetic and healthy animals with increased plasma FFA concentration \[[@CR40]\] and from animals fed high fat diets \[[@CR41]\]. In the present study the activity of SPT increased in each studied muscle in the trained group. The enzyme activity was almost two times (*p* \< 0.001), three times (*p* \< 0.001) and almost four times (*p* \< 0.001) higher in the soleus, red, and white section of the gastrocnemius, respectively, compared to the control group (Fig. [4](#Fig4){ref-type="fig"}a).Table 3Effect of training on the activity of enzymes implicated in sphingolipids metabolism in rat skeletal muscleSPTnSMaseaSMasenCDasealCDaseControlTrainingControlTrainingControlTrainingControlTrainingControlTrainingSoleus9.79 ± 0.9218.81 ± 2.29^c^13.54 ± 1.3512.71 ± 2.4123.37 ± 3.1335.12 ± 6.71^c^1.19 ± 0.110.97 ± 0.14^a^1.48 ± 0.221.16 ± 0.14^a^Gastrocnemius11.10 ± 1.4036.51 ± 5.63^c^16.54 ± 1.1721.57 ± 3.73^b^20.80 ± 3.7552.47 ± 8.19^c^1.17 ± 0.191.11 ± 0.141.53 ± 0.221.16 ± 0.20^a^White section of the Gastrocnemius10.73 ± 1.2842.42 ± 5.98^c^11.63 ± 1.2316.38 ± 3.06^c^9.13 ± 0.6120.81 ± 3.90^c^1.66 ± 0.191.15 ± 0.19^a^1.90 ± 0.181.26 ± 0.15^b^Values are means ± SD (*n* = 8 in each group). The rats were either sedentary (control) or trained on the electrically driven treadmill as described in the methods^a^*p* \< 0.05, ^b^*p* \< 0.01, ^c^*p* \< 0.001 versus the control groupFig. 4Effect of training on the activity of **a** serine palmitoyltransferase, **b** neutral sphingomyelinase, **c** acid sphingomyelinase in three types of rat skeletal muscles. Values are means ± SD (*n* = 8 in each group). The rats were either sedentary (control) or trained on an electrically driven treadmill as described in the methods. ^b^*p* \< 0.01, ^c^*p* \< 0.001 versus the control group. RG, *redsection* of the gastrocnemius; WG, *whitesection* of the gastrocnemius

In the soleus, there was no difference in nSMase activity between the control and trained groups. In the red and white sections of the gastrocnemius, the activity of nSMase increased by 30% (*p* \< 0.01) and by 41% (*p* \< 0.001), respectively, compared to the control group (Fig. [4](#Fig4){ref-type="fig"}b).

The activity of the aSMase increased in each studied muscle in the trained group. The enzyme activity was 1.5 (*p* \< 0.001), 2.5 (*p* \< 0.001) and 2.3 times (*p* \< 0.001) higher in the soleus, red and white sections of the gastrocnemius respectively, compared to the control group (Fig. [4](#Fig4){ref-type="fig"}c).

The activity of nCDase decreased by 19% (*p* \< 0.05) and by 30% (*p* \< 0.05) in the soleus and white section of the gastrocnemius respectively, compared to the control group. The enzyme activity did not change in red section of the gastrocnemius (Fig. [5](#Fig5){ref-type="fig"}a).Fig. 5Effect of training on the activity of neutral (**a**) and alkaline (**b**) ceramidase in rat skeletal muscle. Values are means ± SD (*n* = 8 in each group). The rats were either sedentary (control) or trained on the electrically driven treadmill as described in the methods. ^a^*p* \< 0.05, ^b^*p* \< 0.01, ^c^*p* \< 0.001 versus the control group. RG, *redsection* of the gastrocnemius; WG, *whitesection* of the gastrocnemius

The activity of alkaline ceramidase (alCDase) decreased by 21% (*p* \< 0.05), 24% (*p* \< 0.05) and 34% (*p* \< 0.01) in the soleus, red and white sections of the gastrocnemius respectively, compared to the control group (Fig. [5](#Fig5){ref-type="fig"}b).

Discussion {#Sec16}
==========

Endurance training induces several changes in lipid metabolism in skeletal muscles. The major change is an increased capacity of the muscles to utilize free fatty acids as a source of energy. Certain changes in phospholipid content and composition and the content of triacylglycerols have been also described \[[@CR42], [@CR43]\]. Recent research has provided information on the role of sphingolipids in induction of insulin resistance. Therefore, knowledge of how the ceramide metabolism can be changed seems to be very important for the invention of new treatments to prevent ceramide accumulation. Ceramide metabolism is changed in muscle in rats fed a high fat diet \[[@CR41]\], diabetic and healthy animals with increased plasma FFA concentration \[[@CR40]\], and also after a single-bout of exercise \[[@CR26]\]. There are very few data in the literature concerning the effect of training on the activity of the key enzymes of ceramide metabolism in skeletal muscle. Our results suggest that the regulation of ceramide metabolism depends on the type of exercise. We found that the short-time exercise caused a reduction in ceramide content but exhaustive exercise led to an elevated ceramide content in muscle \[[@CR26]\]. Data from the current study show that training affects the ceramide metabolism in a different way to single-bout exercise. The ceramide level does not change in the trained group although the activities of the key enzymes of ceramide metabolism changed. The data regarding the content of ceramide are in agreement with the results reported previously, where 8 week training did not affect the ceramide content in rat gastrocnemius muscle \[[@CR44]\]. In human skeletal muscle, training did not change the total ceramide content \[[@CR27]\]. However, there are also conflicting data on the ceramide content in trained muscle. Experiments performed on obese subjects showed that endurance training reduces ceramide content and improves glucose tolerance \[[@CR45], [@CR46]\]. It must be mentioned that in these cases, obese people were examined and the ceramide metabolism in obesity can be different than in lean subjects. However, in the literature, there are also data showing that ceramide content decreases in muscle from trained rats \[[@CR25]\]. The possible explanation of this discrepancy could be different analytical techniques used for measurement of the ceramide level in these two studies. In the mentioned work, ceramide content was measured by means of gas--liquid chromatography (GLC) after transmethylation of the ceramide fatty acids. Ceramide was purified by means of thin layer chromatography (TLC). The total content of different ceramides was measured including species containing: sphingosine, sphinganine, phytosphingosine, and homologs as a sphingoid base.

In our work, we have demonstrated that ceramide generation increased (increased activity of SPT, nSMase and aSMase) and decreased ceramides degradation (decreased activity of both CDases isoforms). Because of increased activity of enzymes responsible for ceramide production and decreased activity of enzymes responsible for ceramides degradation, we would expect to have an elevated ceramide content in the muscle, but we did not notice any changes in the ceramides level. We also did not observed any changes in muscle dihydroceramide content between trained and sedentary groups. This suggests that in the trained muscle other enzymes responsible for ceramides degradation/conversion are activated. We suspect that ceramide kinase, sphingomyelin synthase or glucosylceramide synthase are activated. Contribution of these pathways to regulation of ceramide content has not been recognized, so far.

Presently, we reported increased activity of SPT (enzyme catalyzing the reaction of condensation of serine and palmitoyl-CoA) and elevated content of sphinganine (main intermediate in sphingolipids de novo biosynthesis) in trained muscle. The elevation in the activity of SPT and the SPA content during exercise strongly indicates that physical exercise augments de novo sphingolipids synthesis in the muscles. The accumulation of SPA in the skeletal muscles of trained rats was observed also in the former study \[[@CR25]\]. In our work we have observed an increased content of sphinganine-1-phosphate. It seems that sphinganine is directed to SPA1P instead of dhCer in the de novo synthesis pathway. Unfortunately, we have been unable to compare results from SPT activity and SPA1P content with any others because there is no information about SPT activity and SPA1P content in trained muscle.

Moreover, we also noticed increased activity of both isoforms of sphingomyelinases. We assume that increased nSMase activity is the effect of an increased content of TNF-α. During exercise TNF-α concentration increases and this agent is well known as an SMase activator \[[@CR47]\]. Increased activity of nSMase was also previously observed in trained rat muscles \[[@CR25]\]. In the literature there are also conflicting results related to nSMase activity. Data from trained muscle in human subjects showed that training does not affect nSMase activity \[[@CR27]\].

Besides increased activities of enzymes responsible for ceramide production (SPT, n- and aSMase), we have simultaneously observed decreased activity of both isoforms of CDases. We cannot compare this result with any others studies because this is the only study when the enzymes activities were measured in trained muscles. In our work we did not observe any changes in Sph content and this result is in line with the results obtained previously \[[@CR25]\].

It is well known that accumulation of ceramides, diacylglycerols and LCACoA in skeletal muscle is responsible for induction of insulin resistance. In our work, although ceramide content did not change in trained muscle, increased insulin sensitivity was observed---HOMA-IR values were significantly lower in trained animals compared to sedentary rats (Table [1](#Tab1){ref-type="table"}).

In summary, ceramide content does not change in the trained group although the animals were more insulin sensitive, Moreover, the activity of enzymes responsible for ceramide production (SPT, nSMase, aSMase) increased and the activity of enzymes responsible for ceramide degradation (nCDase, alCDase) decreased. These results suggest that in trained muscle other metabolic pathways are activated and have an effect on the ceramide content.
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